Charles A. Bancroft - 30 Jun 2026 Form 4 Insider Report for Kodiak Sciences Inc. (KOD)

Reporting relationship: Director
Issuer ticker: KOD
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2026, 17:52:09 UTC
Prior SEC filing: 02 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ David Peinsipp, Attorney-in-Fact for Charles Bancroft

Key filing fact

Charles A. Bancroft filed Form 4 for Kodiak Sciences Inc. (KOD) on 02 Jul 2026.

Key facts

This page summarizes Charles A. Bancroft's Form 4 filing for Kodiak Sciences Inc. (KOD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Jul 2026, 17:52.

Change

Previous filing in this sequence was filed on 02 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001480250 Primary reporting owner

Bancroft Charles A

Relationship: Director
Address: 1250 PAGE MILL ROAD, PALO ALTO
Signature: /s/ David Peinsipp, Attorney-in-Fact for Charles Bancroft
Signature date: 02 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KOD transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +17,731
Change %
Price: $0.000000^*
Shares after: 17,731
Date: 30 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,731
Exercise price: $38.96
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 30, 2027 or one (1) day prior to the Issuer's next annual meeting occurring after the grant date, in each case, provided the Reporting Person continues to serve as a member of the Issuer's board of directors through the applicable vesting date.